A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer. Cai Y, Guo Y, Ma W, Cheng P, et al. Eur J Endocrinol 2025;192:128-140.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cai Y, Guo Y, Ma W, Cheng P, et al. A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer. Eur J Endocrinol 2025;192:128-140.
PMID: 39996468